THEVETIA PERUVIANA ROOTS EXTRACT MEDICATED GOLD NANOPARTICLES AND ITS UREASE INHIBITORY ACTIVITY
DOI:
https://doi.org/10.22159/ijap.2021.v13s1.Y1026Keywords:
Thevetia peruviana, Extract, Nanoparticles, Urease activityAbstract
Objective: The main objective of the current research work was synthesized of gold nanoparticles (AuNPs) of Thevetia peruviana aqueous extract,
characterization, and screening for urease enzyme inhibitory activity.
Methods: AuNPs were synthesized by mixing 1 mM gold salt solution with T. peruviana aqueous extract without any reducing agents. The prepared
AuNPs were characterized using UV–visible spectroscopy, Fourier transform infrared spectroscopy, and scanning electron microscopy techniques. The
synthesized AuNPs were assessed for in vitro urease enzyme inhibitory activity at 0.2 μg in comparison with the aqueous extract.
Results: In this finding, we synthesized the AuNPs of T. peruviana aqueous extract for the 1st time. The AuNPs exhibited significant stability at
room temperature. The AuNPs showed significant urease inhibitory activity with IC50 67.56±1.67 at 0.2 μg as compared to aqueous extract which
exhibited good activity with IC50 39.21±1.32 μ at 0.2 mg, against standard thiourea (IC50=21.00±1.16). The formation of AuNPs correlates due to active
phytochemical present in extract which is responsible for synthesizing NPs.
Conclusion: T. peruviana extract and prepared AuNPs are an outstanding urease enzyme inhibitor and are capable of making fine NPs. Application:
The synthesized AuNPs of T. peruviana aqueous extract which significant urease inhibitory activity may allow us to discover NPs for potentially
effective and safe nanoherbal therapy.
Downloads
References
of Thevetia peruviana (yellow oleander) poisoning. J Wilderness Med
1992;3:382-6.
2. Rao MA, Venkata E, Visweswaram D. Effect of certain structural
changes in cardiac glycosides of Thevetia peruviana on their toxicity. J
Mol Cell Cardiol 1978;10 Suppl 1:86-8.
3. Rauf A, Bawazeer S, Naseer M, Alhumaydhi FA, Aljohani AS, Habib A,
et al. In vitro ?-glycosidase and urease enzyme inhibition profile of
some selected medicinal plants of Pakistan. Nat Prod Res 2020;15:1-6.
4. Roberts DM, Southcott E, Potter JM, Roberts MS, Eddleston M,
Buckley NA. Pharmacokinetics of digoxin cross-reacting substances
in patients with acute yellow oleander (Thevetia peruviana) poisoning,
including the effect of activated charcoal. Ther Drug Monit 2006;28:784-92.
5. Kareru PG, Keriko JM, Kenji GM, Gachanja AN. Anti-termite and
antimicrobial properties of paint made from Thevetia peruviana (Pers.)
Schum oil extract. Afr J Pharm Pharmacol 2010;4:87-9.
6. Rauf A, Uddin G, Raza M, Patel S, Bawazeer S, Hadda TB, et al.
Urease inhibition potential and molecular docking of dihydroquercetin
and dihydromyricetin isolated from Picea smithiana (wall) Boiss.
Biomed Res 2017;28:10026-32.
7. Rauf A, Raza M, Saleem M, Ozgen U, Karaoglan ES, Renda G, et al.
Carbonic anhydrase and urease inhibitory potential of various plant
phenolics using in vitro and in silico methods. Chem Bioderivers
2017;16:1-24.
8. Islam NU, Jalil K, Shahida M, Muhammad N, Rauf A. Pistacia
integerrima gall extract mediated green synthesis of gold nanoparticles
and their biological activities. Arab J Chem 2020;12:2310-9.
9. Khattak A, Ahmad B, Rauf A, Bawazeer S, Farooq U, Ali J, et al. Green
synthesis, characterisation and biological evaluation of plant-based
silver nanoparticles using Quercus semecarpifolia Smith aqueous leaf
extract. IET Nanobiotechnolol 2019;13:36-41.
